Original InvestigationPulsed Field Ablation in Patients With Persistent Atrial Fibrillation
Central Illustration
Key Words
Abbreviations and Acronyms
Cited by (0)
The trials were supported by the manufacturer of the ablation system, Farapulse Inc. Dr. Reddy holds stock in Farapulse; has served as a consultant for Biosense Webster and Boston Scientific; has served as a consultant for Abbott, Ablacon, Acutus Medical, Affera, Apama Medical, Aquaheart, Atacor, Autonomix, Axon, Backbeat, BioSig, Biotronik, Cardiofocus, Cardionomic, CardioNXT/AFTx, Circa Scientific, Corvia Medical, Dinova-Hangzhou Nuomao Medtech Co., Ltd., East End Medical, EBR, EPD, Epix Therapeutics, EpiEP, Eximo, Fire1, Impulse Dynamics, Javelin, Kardium, Keystone Heart, LuxCath, Medlumics, Medtronic, Middlepeak, Nuvera, Philips, Sirona Medical, Stimda, Thermedical, and Valcare (not related to this manuscript); and has equity in Ablacon, Acutus Medical, Affera, Apama Medical, Aquaheart, Atacor, Autonomix, Backbeat, BioSig, Circa Scientific, Corvia Medical, Dinova-Hangzhou Nuomao Medtech Co., Ltd., East End Medical, EPD, Epix Therapeutics, EpiEP, Eximo, Fire1, Javelin, Kardium, Keystone Heart, LuxCath, Manual Surgical Sciences, Medlumics, Middlepeak, Newpace, Nuvera, Sirona Medical, Surecor, Valcare, and Vizaramed (not related to this manuscript). Dr. Anic has received grant support from and served as a consultant for Farapulse. Dr. Koruth has received grant support from and served as a consultant for Farapulse; has served as a consultant for Medtronic, Vytronus, Abbott, and Cardiofocus (not related to this manuscript); and has received grant support from Vytronus, Cardiofocus, Luxcath, Affera, LuxCath, and Medlumics (not related to this manuscript). Dr. Petru has received grant support from Farapulse. Dr. Dukkipati holds stock in Farapulse; and has received grant support from Biosense Webster. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
The authors attest they are in compliance with human studies committees and animal welfare regulations of the authors’ institutions and Food and Drug Administration guidelines, including patient consent where appropriate. For more information, visit the JACC author instructions page.